A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy Safety and Tolerability of Albumin....... Grant uri icon

Overview

total award amount

  • 176093.38

direct costs

  • 140874.30

sponsor award id

  • HGS1008-C1060 US-043
  • HGS1008-C1060US-043

Background

Time

date/time interval

  • December 19, 2006 - December 12, 2009

Identity

DSR Number

  • 07060469
  • 07103160
  • 08090768
  • 08111259

PeopleSoft Contract Number

  • 00063131

local award id

  • 00063131